SCHEMBL22589762

SCHEMBL22589762

N#Cc1cccc(-c2nnc(NC(=O)c3ccc(SC(F)(F)F)cc3)o2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADCY1 Q08828 9/20 0.51
▸ HTT P42858 3/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ LMNA P02545 3/20 0.51
▸ OPRK1 P41145 2/20 0.51
▸ CCR6 P51684 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ TP53 P04637 2/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ ADCY8 P40145 5/20 0.49
▸ MAPK14 Q16539 1/20 0.48
▸ KDM4E B2RXH2 4/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ ALOX12 P18054 1/20 0.48
▸ CXCR5 P32302 1/20 0.48
▸ APLNR P35414 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22589765 0.87 ADCY1 (0.59) ADCY1HTTMEN1KMT2ALMNA
SCHEMBL22589708 0.86 ADCY1 (0.54) ADCY1HTTMEN1KMT2ALMNA
SCHEMBL22589843 0.86 ADCY1 (0.67) ADCY1HTTMEN1KMT2ALMNA
SCHEMBL22589771 0.86 LMNA (0.61) ADCY1HTTMEN1KMT2ALMNA
SCHEMBL22589706 0.85 ADCY1 (0.67) ADCY1HTTLMNAOPRK1CCR6
SCHEMBL22594335 0.84 ABL1 (0.54) ADCY1HTTMEN1KMT2ALMNA
SCHEMBL22589766 0.81 SMN1; SMN2 (0.67) ADCY1HTTMEN1KMT2ALMNA
SCHEMBL22589739 0.80 ADCY1 (0.57) ADCY1HTTMEN1KMT2ALMNA
SCHEMBL22589750 0.80 ADCY1 (0.62) ADCY1HTTLMNAOPRK1CCR6
SCHEMBL22589702 0.80 ADCY1 (0.77) ADCY1MEN1KMT2ALMNAOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220249447-A1 CF3-, OCF3-, SCF3-, and SF5-Containing Antibacterial Agents PURDUE RESEARCH FOUNDATION 2022-08-11 — — US disclosed
EP-3958679-A1 CF3-, OCF3-, SCF3- AND SF5-CONTAINING ANTIBACTERIAL AGENTS Purdue Research Foundation (US) 2022-03-02 — — EP disclosed
WO-2020219792-A1 CF3-, OCF3-, SCF3- AND SF5-CONTAINING ANTIBACTERIAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2020-10-29 — — WO disclosed
WO-2020219792-A1 CF3-, OCF3-, SCF3- AND SF5-CONTAINING ANTIBACTERIAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2020-10-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220249447-A1 CF3-, OCF3-, SCF3-, and SF5-Containing Antibacterial Agents SFXN3, CCR3, SF3A3 ADCY1 4672/4885HTT 3590/4885MEN1 4209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback